TrialBritish journal of haematology2025

Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies.

Michael R Savona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.